Japanese company profile · 6988

NITTO DENKO CORPORATION

In its FY2025 public filing, NITTO DENKO CORPORATION reports Industrial tape, Optoelectronics, Human Life. The page shows business-level revenue and profit where the source disclosures support comparison.

Original Japanese company name: 日東電工株式会社

English company name recorded in Japan's EDINET filer data. English company name source

Reported company-wide figures

Company revenue
¥1.03T ↗
FY2025 · fiscal year ended March 2026
Company profit
¥183.62B ↗
FY2025 · fiscal year ended March 2026
Profit margin
17.9% ↗
FY2025 · fiscal year ended March 2026

What does this company do?

What does this company do?

NITTO DENKO CORPORATION's largest reported business by revenue in FY2025 was Optoelectronics.

The business with the highest reported segment profit in FY2025 was Optoelectronics.

FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.

Business structure

How does it make money?

BusinessRevenue from external customersRevenue shareSegment profit (loss)
Optoelectronics¥524.6B ↗51.0%¥149.87B ↗
Industrial tape¥364.83B ↗35.5%¥51.66B ↗
Human Life¥137.25B ↗13.3%−¥5.04B ↗

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.

Original Japanese label
Industrial tape
インダストリアルテープ
Optoelectronics
オプトロニクス
Human Life
ヒューマンライフ
Life Sciences
ライフサイエンス
Revenue from external customers
外部顧客売上
Segment profit (loss)
セグメント利益(損失)
Original Japanese label
Industrial tape
インダストリアルテープ
Optoelectronics
オプトロニクス
Human Life
ヒューマンライフ
Life Sciences
ライフサイエンス
Revenue from external customers
外部顧客売上
Segment profit (loss)
セグメント利益(損失)

Reported Revenue from external customers by business over time

Reported Revenue from external customers by business over time

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Industrial tape¥327.62B¥334.46B¥347.21B¥351.7B¥364.83B
Optoelectronics¥452.33B¥469.33B¥449.97B¥537.48B¥524.6B
Human Life—¥123.97B¥116.63B¥123.2B¥137.25B
Life Sciences¥47.7B————

All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.

What is growing?

What is growing?

Business revenue growth

This describes a reported period; it is not a forecast.

What has changed?

What has changed?

Not disclosed or not safely comparable in the available filings.

Source

Public filing

FY2025 · fiscal year ended March 2026

The source document may be in Japanese.

Filing ID: S100YCAR

View original filing ↗

Ask about this company

Ask about this company

The source document may be in Japanese.

根拠となる資料